Tim Wither – Managing Director – Maximus Resources (ASX:MXR) is a gold and nickel exploration company.
Copyright 2023 – Finance News Network
Source: Finance News Network
15 Nov 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Dr Michael Baker provides an update on the company.
Read More23 Feb 2024 - Discover Sunshine Metals' strategic focus on Queensland's prolific gold and base metal districts, unveiling promising exploration ventures and recent resource upgrades.
Read More21 Jun 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses shipping an alpha product to a customer, and the development roadmap for the company.
Read More22 Sep 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses Evergrande, the Chinese economy, implications for the Australian equity market and monetary policy.
Read More28 Feb 2024 - Tim Mason - CEO - Eagle Mountain Mining Limited (ASX:EM2), is a copper focused exploration and development Company with a key objective of becoming a low emission producer at its high-grade Oracle Ridge project in Arizona, USA, to supply the rapidly growing green energy market.
Read More03 Jun 2024 - Chris Gosselin interviews Dan Nicolaides on how Digital Asset Funds Management uses crypto market volatility for stable returns and risk management.
Read More07 Nov 2023 - Elementos Limited (ASX:ELT) Managing Director Joe David provides an update on the company's tin projects in Tasmania and Spain.
Read More18 May 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's pipeline and discusses the recent licensing of an asset from UCLA.
Read More20 Mar 2024 - Dotz Nano Limited (ASX:DTZ) CEO Sharon Malka discusses development of Dotz Earth, a new-generation sorbent technology for carbon dioxide capture.
Read More07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
Read More
